METTL16 and neoplasm: METTL16 reduces the stability of PD-L1 mRNA via its m6A modification, consequently increasing the number of tumor-infiltrating immune cells in the immune microenvironment of cervical cancer, such as plasma cells and regulatory T cells [221].